Orphan Drug Status Granted to Lung Therapeutics Drug by The European Commission
The European Commission (EC) has awarded orphan medicinal product designation to Austin-based pharmaceutical company Lung Therapeutics, Inc.’s LTI-01 for the treatment of empyema as a complication from pneumonia.
by Leonor Mateus Ferreira
BIONEWS TEXAS